Previous reports have cited CD68 as a pan-macrophage marker and CD163 as an M2-like macrophage marker.26 Staining of primary melanoma specimens has shown that CD68+ cells are significantly less prevalent than CD163+ cells. This evidence concerns the gene CD163 and melanoma.